Gevo, Inc. announced the appointment of K'Lynne Johnson to its Board of Directors, effective November 4, 2026. The appointment was approved by the Board and makes Johnson a Class II director, with a term that will expire at the annual meeting of stockholders to be held in 2027.
According to the filing, Ms. Johnson will receive an annual cash retainer of $85,000 and an equity grant valued at $63,000 for her service as a non-employee director. The equity award will be issued pursuant to the Company’s Amended and Restated 2010 Stock Incentive Plan. She is also eligible for additional annual grants of equity and other compensation consistent with the Company’s compensation policy. The filing notes that the Board has determined Ms. Johnson to be an independent director under the applicable Nasdaq listing standards.
The company stated that Ms. Johnson entered into the Company’s customary form of indemnification agreement upon her appointment and that there are no understandings or arrangements regarding her selection.
Ms. Johnson brings more than three decades of experience in innovation and executive leadership, with a focus on sustainable technologies, global research and development, and manufacturing operations. She is the founder and former President and Chief Executive Officer of Elevance Renewable Sciences, Inc., a specialty chemicals company. Previously, she held senior leadership roles at BP Innovene Inc., BP Chemicals, and Amoco Corporation. Currently, she serves as a director of FMC Corporation, Trinseo PLC, J.M. Huber Corporation, and BlueScope Steel Limited, and is the independent board chair of DMC Biotechnologies.
Gevo Chief Executive Officer Paul Bloom commented on the appointment, stating that Ms. Johnson brings a powerful combination of strategic, operational, and governance experience to the company.
